Department of Developmental and Regenerative Biology, Institute of Molecular Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467-8601, Japan.
Genes (Basel). 2011 Jan 14;2(1):107-30. doi: 10.3390/genes2010107.
Neural stem cells (NSCs) are capable of producing a variety of neural cell types, and are indispensable for the development of the mammalian brain. NSCs can be induced in vitro from pluripotent stem cells, including embryonic stem cells and induced-pluripotent stem cells. Although the transplantation of these exogenous NSCs is a potential strategy for improving presently untreatable neurological conditions, there are several obstacles to its implementation, including tumorigenic, immunological, and ethical problems. Recent studies have revealed that NSCs also reside in the adult brain. The endogenous NSCs are activated in response to disease or trauma, and produce new neurons and glia, suggesting they have the potential to regenerate damaged brain tissue while avoiding the above-mentioned problems. Here we present an overview of the possibility and limitations of using endogenous NSCs in regenerative medicine.
神经干细胞(NSCs)能够产生多种神经细胞类型,对哺乳动物大脑的发育不可或缺。NSCs 可从多能干细胞(包括胚胎干细胞和诱导多能干细胞)体外诱导产生。虽然移植这些外源性 NSCs 是改善目前无法治疗的神经疾病的一种潜在策略,但在实施过程中存在多种障碍,包括致瘤性、免疫性和伦理学问题。最近的研究表明,NSCs 也存在于成年大脑中。内源性 NSCs 在疾病或创伤时被激活,并产生新的神经元和神经胶质细胞,这表明它们有可能在避免上述问题的同时,再生受损的脑组织。本文概述了利用内源性 NSCs 进行再生医学的可能性和局限性。